<SEC-DOCUMENT>0001193125-16-473629.txt : 20160223
<SEC-HEADER>0001193125-16-473629.hdr.sgml : 20160223
<ACCEPTANCE-DATETIME>20160223163031
ACCESSION NUMBER:		0001193125-16-473629
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160223
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160223
DATE AS OF CHANGE:		20160223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONMED CORP
		CENTRAL INDEX KEY:			0000816956
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				160977505
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-16093
		FILM NUMBER:		161448707

	BUSINESS ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
		BUSINESS PHONE:		315-624-3215

	MAIL ADDRESS:	
		STREET 1:		525 FRENCH ROAD
		CITY:			UTICA
		STATE:			NY
		ZIP:			13502
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d111751d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT
TO SECTION 13 OR 15 (d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported): February 23, 2016 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>CONMED CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>New York</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-16093</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>16-0977505</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>525 French Road </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Utica, New York 13502 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices, including zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(315) 797-8375 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address if changed since last report.) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 23, 2016, on the recommendation of the Corporate Governance and Nominating Committee, pursuant to Section&nbsp;2.2 of the Amended
and Restated By-Laws of CONMED Corporation (as adopted on April 29, 2011), the Board of Directors appointed Martha Goldberg Aronson to be on the CONMED Corporation Board of Directors. A copy of the press release issued on February 23, 2016
describing the background and qualification of Ms. Aronson is attached to this Form 8-K as Exhibit 99.1. Ms.&nbsp;Aronson was appointed to the Compensation Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no understanding or arrangement between Ms. Aronson or any third parties pursuant to which she was selected or nominated as a
director, and there are no related-party transactions which would be required to be disclosed under Item 404(a) of Regulation S-K with respect to Ms. Aronson. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a non-employee director, Ms. Aronson will participate in the Director Fee Plan, as further described in the Annual Proxy Statement dated
April 17, 2015. In addition, the Board of Directors awarded Ms. Aronson 1,000 Restricted Stock Units, subject to 100% vesting upon the completion of one full year of service as a director. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;8.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Other Events. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On February 23 2016, CONMED Corporation announced it will be paying a
quarterly cash dividend of $0.20 per share on April&nbsp;5, 2016 to all shareholders of record as of<B> </B>March 15, 2016. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"><U>Exhibits</U> </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:75.45pt; font-size:8pt; font-family:Times New Roman"><B>Description of Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release issued by CONMED Corporation on February 23, 2016</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONMED CORPORATION</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Registrant)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Luke A. Pomilio</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Luke A. Pomilio</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive VP, Finance and Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: February 23, 2016 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:66.80pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release issued by CONMED Corporation on February 23, 2016</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d111751dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g111751g0223195123336.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>NEWS RELEASE </B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman"><B>CONTACT:</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman"><B><I>CONMED Corporation</I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman"><B>Luke A. Pomilio</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman"><B>Chief Financial Officer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman"><B>315-624-3202</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONMED Corporation Adds Health Care Executive Martha Goldberg Aronson to its Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Utica, New York, February 23, 2016 &#150; CONMED Corporation (NASDAQ: CNMD)</B> today announced that it has added Martha Goldberg Aronson to its Board of
Directors, effective immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;We are pleased to welcome Martha to our Board of Directors,&#148; commented Mark Tryniski, Chairman of
CONMED&#146;s Board of Directors. &#147;We look forward to leveraging her years of diversified health care experience, financial management, and international expertise to help CONMED deliver on a myriad of opportunities within its key
markets.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Curt R. Hartman, President and Chief Executive Officer of CONMED, added, &#147;Martha&#146;s proven track record of executive and
operational leadership in the health care industry will make her a meaningful contributor in supporting CONMED&#146;s growth strategy and helping us drive increased shareholder value.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms. Aronson most recently served as Executive Vice President and President, Global Healthcare at Ecolab, Inc., where she was responsible for the profit and
loss of the company&#146;s global healthcare division with approximate revenues of $600 million. She also served as a member of Ecolab&#146;s Executive Committee. She previously was President, North America at Hill-Rom Holdings, Inc., where she
oversaw all aspects of a $1 billion business. Prior to Hill-Rom, Ms. Aronson spent 18 years at Medtronic, Inc., where she was also a member of the Executive Committee, in roles of increasing responsibility, including her last position as Senior Vice
President and Chief Talent Officer. Her other roles at Medtronic included Vice President, Investor Relations, as well as an international assignment where she was Vice President responsible for profit and loss for five businesses in Western Europe
with over $450 million in revenue. Ms. Aronson also held several managerial positions at Medtronic in marketing and product management. Ms. Aronson began her distinguished career as an associate consultant at Bain and Company, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms. Aronson is currently a member of the Board of Directors at Hutchinson Technology, Inc. (NASDAQ: HTCH) and the Guthrie Theater. Ms. Aronson has received a
number of awards and accolades throughout her professional career for her outstanding leadership skills and accomplishments in the health care industry, including being named as one of the 35 most influential women in health care in Minnesota in
2014. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am excited to be joining CONMED&#146;s team at such a pivotal time in the Company&#146;s history,&#148; commented Ms. Aronson. &#147;I look
forward to working with CONMED&#146;s Board and management team as they continue to revitalize the business.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms. Aronson received her MBA from the
Harvard Graduate School of Business Administration and a Bachelor of Arts in Economics from Wellesley College. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About CONMED Corporation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company&#146;s products are used by
surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. The Company distributes its products worldwide from several manufacturing locations. CONMED has a direct
selling presence in 17 countries and international sales constitute approximately 50% of the Company&#146;s total sales. Headquartered in Utica, New York, the Company employs approximately 3,500 people. For more information, visit www.conmed.com.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Forward Looking Information </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press
release contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. For example, all statements regarding the payment of cash dividends in future periods are forward-looking statements.
The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company&#146;s performance on a going-forward basis. The forward-looking statements in this
press release involve risks and uncertainties which could cause actual results, performance or trends, to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. The Company believes that all
forward-looking statements made by it have a reasonable basis, but there can be no assurance that management&#146;s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.
</I></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g111751g0223195123336.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g111751g0223195123336.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  .\# 2(  A$! Q$!_\0
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M&].\*Z+#I>F0B.&,?,V/FD;NS'N36?\ $+0KGQ)X&U/3+0C[1+%F,'^(CG%
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MK^J+HGA^_P!389%M T@'J0./UK1KG_&B6]WX6OM,EN8X9KV%H85=L%W(X H
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MT 2^ O$T?BSP=8:HI'FM&$F4'[L@X8?G7E7Q+GF^(/Q2TKP/9.39V;[[QE/
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,'-='10 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
